HOT NEWS
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon » Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced results from two Phase 3 trial...
Nycomed on track in 2009 with strong growth in Key Products » Nycomed was on track in 2009, with strong growth in Key Products and most emerging markets. Pantopra...
Bayer Successful in a Difficult Environment » 2009 was operationally one of the strongest years for the Bayer Group. "We were successful in a diff...
Phase III study of Avastin in advanced stomach cancer did not meet primary endpo... » Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the topline results from a global phase III trial inves...
Sanofi Pasteur's A(H1N1) Vaccine HUMENZA®* Recommended by European Medicines Ag... » Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announc...
FY2009: Merck KGaA Revenues Rise by 2.1% to € 7.7 Billion » Merck KGaA announced that Group total revenues rose 2.1% in 2009 - meeting the guidance given earlie...
GSK receives positive opinions in Europe for Tyverb® and Votrient™ » GlaxoSmithKline (GSK) announced that the European Medicines Agency's Committee for Medicinal Product...
My child matters Supports Seven New Childhood Cancer Care Projects » On the International Childhood Cancer Day, the International Union Against Cancer (UICC) and sanofi-...
Abbott Completes Acquisition of Solvay Pharmaceuticals » Abbott (NYSE: ABT) today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisit...
Merck Receives European Approval for ELONVA® (corifollitropin alfa injection) » Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European C...
EMEA
The European Medicines Agency (EMEA)The European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.

EMEA RSS Channel
Filter     Display # 
# Article Title Hits
1 European Medicines Agency advises of risk of fever in young children following vaccination with Pandemrix 384
2 EMEA makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents 565
3 European Medicines Agency 2009 mid-year report shows it is still on target, despite influenza pandemic activities 425
4 European Medicines Agency implements internal reorganisation 472
5 European Medicines Agency recommends authorisation of additional vaccine for influenza pandemic (H1N1) 2009 740
6 European Medicines Agency recommends authorisation of two vaccines for influenza pandemic (H1N1) 2009 738
7 The bacterial challenge - time to react 555
8 EMEA and FDA launch Good Clinical Practice Initiative 884
9 European Medicines Agency review of pandemic vaccines underway 420
10 European Medicines Agency update on safety of insulin glargine 531
11 European Medicines Agency update on safety of insulin glargine 642
12 European Medicines Agency recommends withdrawal of dextropropoxyphene-containing medicines 652
13 European Medicines Agency launches public consultation on new transparency policy 506
14 European public health agencies evaluate antibiotic resistance of Staphylococcus aureus 405
15 WHO declares influenza pandemic - European Medicines Agency initiates crisis-management plan 415
16 EU-wide recall of Raptiva (efalizumab) to be initiated 331
17 Public statement on possible interaction between clopidogrel and proton pump inhibitors 582
18 European Medicines Agency recommendations on extension of shelf life for Tamiflu 675
19 EMEA-coordinated PROTECT project has been accepted for funding by the Innovative Medicines Initiative Joint Undertaking 634
20 EMEA, EC and Health Canada agree implementation plan for confidentiality arrangement 476
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share

Banner